Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study. - Test2 - elhamkhani - TriplyDB

Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study.

Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study.

http://www.wikidata.org/entity/Q30410885

about

Hypertension and cognitive dysfunction in elderly: blood pressure management for this global burden Relationship Between Antihypertensive Medications and Cognitive Impairment: Part I. Review of Human Studies and Clinical Trials Alzheimer's disease and type 2 diabetes via chronic inflammatory mechanisms Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis Can the Treatment of Hypertension in the Middle-Aged Prevent Dementia in the Elderly?Genetic suppression of β2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies.Cardiovascular medication burden in dementia disorders: a nationwide study of 19,743 dementia patients in the Swedish Dementia Registry.Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer's disease.Losartan improves measures of activity, inflammation, and oxidative stress in older mice.Use of diuretics is associated with reduced risk of Alzheimer's disease: the Cache County Study Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms.Baseline subjective memory complaints associate with increased risk of incident dementia: the PREADVISE trial Group-based exercise and cognitive-physical training in older adults with self-reported cognitive complaints: The Multiple-Modality, Mind-Motor (M4) study protocol.Modulation of Renin-Angiotensin System May Slow Conversion from Mild Cognitive Impairment to Alzheimer's Disease.Effects of vascular risk factors, statins, and antihypertensive drugs on PiB deposition in cognitively normal subjects.The Role of Cardiovascular Risk Factors and Stroke in Familial Alzheimer Disease.From Neurodegeneration to Brain Health: An Integrated Approach.Antihypertensive Therapies and Cognitive Function: a Review.Evidence to Consider Angiotensin II Receptor Blockers for the Treatment of Early Alzheimer's Disease.Impact of renin-angiotensin system-targeting antihypertensive drugs on treatment of Alzheimer's disease: a meta-analysis.Age of onset of hypertension and risk of dementia in the oldest-old: The 90+ Study.Vascular Risk Factors and Cognition in Parkinson's Disease.Angiotensin-(1-7) is Reduced and Inversely Correlates with Tau Hyperphosphorylation in Animal Models of Alzheimer's Disease.Aβ Amyloid Pathology Affects the Hearts of Patients With Alzheimer's Disease: Mind the Heart.Association between Antihypertensive Drug Use and the Incidence of Cognitive Decline and Dementia: A Meta-Analysis of Prospective Cohort Studies.Advancing Alzheimer's research: A review of big data promises.Blood Pressure Lowering Medication, Visit-to-Visit Blood Pressure Variability, and Cognitive Function in Old Age.Angiotensin II AT1 receptor blockade by telmisartan reduces impairment of spatial maze performance induced by both acute and chronic stress.Within the Brain: The Renin Angiotensin System.The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment?National Trends in Outpatient Antihypertensive Prescribing in People with Dementia in the United States.[Role of cardiovascular risk factors in the etiology of dementia].Associations of Angiotensin Converting Enzyme-1 and Angiotensin II Blood Levels and Cognitive Function.Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's disease

P2860

Q28074728-09E715EE-93C9-413A-A215-749DDD4607AE Q28076516-7914EAD4-EC60-4AB5-8A8D-3DBBD1780943 Q28086892-CBA197EB-D257-4E26-934C-2A939C1440EE Q28648344-E89CB2E5-6479-43FC-9149-F4910898E328 Q30235369-C774E992-23BD-48D1-86E8-0435F452F458 Q31076577-DAD7DF93-84EC-4D9A-B524-AD0382544594 Q33847602-6A8F2E0F-457A-477D-AEBD-70C24350024A Q33892785-49BB4111-CF4B-4679-AB15-854E7EC1CC74 Q34458459-5872FD7F-1E69-4D70-B29F-9B7B260E3B12 Q34616302-255970AA-5A72-4C4B-A493-C56BDA041476 Q35195840-4AB03735-0EA0-4654-A99B-6DFBE33789F4 Q35564715-196C9966-1D74-46DE-AFD7-8AB5E7FA4DF5 Q35846653-B39C9399-4634-46DC-9E72-36D0D564D4B2 Q35895383-43238B81-4DD0-4501-8926-C4F1A556E728 Q36551172-1673EC16-EAD6-4B63-827E-31589925ACBD Q36933792-78ADD471-7338-4985-B998-685833ACDBD9 Q37502130-C5924141-3C6B-4E9A-82BF-F1B6314DA4AE Q38365566-1F1248D0-6044-4EC0-8EDF-CA36A3E57FA5 Q38571859-CD4426CE-E60B-42B3-A4BF-99602C014056 Q38781028-6DF36AB4-93AD-4522-A944-B12D9923DD95 Q39034947-43196976-4ED2-4B02-A0C0-5636C75A7641 Q40370973-37E7BC56-3EC0-4764-9106-DF2359F8D2D7 Q40902411-CA82940A-B0AF-4C21-920C-72769FF8D79A Q46152975-A3CC83B7-2A8C-4ACC-AD40-436521AE78DA Q47094954-34A207DA-344B-4DE6-AE19-362B5A7AE9B1 Q47147626-809433B0-956D-472B-8CD4-F6439D205033 Q48036293-6F332882-AD48-4DE4-8557-CCDF58015524 Q50578868-C8E7A4BE-349E-4A19-B092-DD0052A83F8D Q50679658-FC96CBE6-5A58-4767-A699-725B3BDDF134 Q51762826-3FA42FEF-EB73-409B-8269-9CC06CA10FCF Q52347539-01420CDD-D6EB-4CC8-822B-62CFF141BAAD Q52872937-FB26480C-9AC9-44D6-947A-196A2D8579E7 Q53360943-8C363989-BB47-4BA7-BE05-4432994DD8CF Q55347760-92592759-4360-441A-8BB4-C9C3D605CEE9 Q58566954-C0B950F7-870F-41B4-94E5-B9AD582ACB70

P2860

Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study.

http://www.wikidata.org/entity/Q30410885

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Antihypertensive drugs decreas ...... go Evaluation of Memory Study.

@ast

Antihypertensive drugs decreas ...... go Evaluation of Memory Study.

@en

type

label

Antihypertensive drugs decreas ...... go Evaluation of Memory Study.

@ast

Antihypertensive drugs decreas ...... go Evaluation of Memory Study.

@en

prefLabel

Antihypertensive drugs decreas ...... go Evaluation of Memory Study.

@ast

Antihypertensive drugs decreas ...... go Evaluation of Memory Study.

@en

P1433

Q30410885-DEE3A8D9-911C-4639-BBEB-A033854AEB0B

P1476

Q30410885-340E3A1D-686E-4F1A-A278-0D2FB1CA4D38

P2093

Q30410885-13AFB0FF-6264-4732-A749-255424F25A08

Q30410885-3A81FDA0-64EE-4E3A-867C-ACE2E5DE9DC9

Q30410885-3EF9030C-6343-4B7F-B8DB-C44A681F4C62

Q30410885-5FB5C972-B0D9-424E-BFF8-308F3D3BA4D3

Q30410885-71EF4E9F-3744-4A59-B453-34C5DD4A013B

Q30410885-7344F461-5437-49F6-84C3-75DDD1C25BC8

Q30410885-82F0A6DA-D4E7-4B55-B404-0D272CDA4BB9

Q30410885-8EFAF497-0DF8-4669-AAE1-A961F6892AAA

Q30410885-B4903105-1E24-4DB1-B9BD-6870ADFC1465

Q30410885-DDC0C619-8E36-468A-96F4-2B2D3DC9BC11

P2860

Q30410885-005F64C7-AB3D-443E-84C7-DE35B9CD29D3

Q30410885-06AD3FCE-257C-4CA0-A78B-E97F127F756F

Q30410885-0B78F667-1814-4CFF-B042-EE38C3894B3C

Q30410885-11BADC7D-DAA1-499B-8BC1-1651309D1B50

Q30410885-26C4E47E-C3FA-4EF6-BAF4-2BE2808C374C

Q30410885-3A7235F6-66EE-4369-A095-E71603C5FF14

Q30410885-52B3508A-0BA5-44E1-82C9-77875A67AFF4

Q30410885-57C8CC91-7D7D-4E41-9337-4DA1BA87CB4E

Q30410885-5AB07211-C1A9-486E-82C4-8A414D5C7131

Q30410885-5E0F437C-7A06-4DC0-8EC1-43F58A837998

P304

Q30410885-82DB36AF-FB48-4E9E-A2AA-15D356C8FD60

P31

Q30410885-87BF1778-5793-44F3-B885-AB0E88B01388

P356

Q30410885-CF608201-9766-42DE-9FE9-D87C9175327E

P407

Q30410885-198C283F-9704-4EBA-B821-769B14D09E70

P433

Q30410885-F8C6B243-48DB-4E91-917D-CCA3A17C2ACE

P478

Q30410885-7B9EDC41-F4B6-49AB-BCA3-B84B82BA632C

P50

Q30410885-BBE0F65C-239C-4F57-BC94-A27028F3D04A

Q30410885-BE5221AD-67D9-4742-B5E4-4354F55AF60E

P577

Q30410885-0D041209-8E65-4A4F-9282-C23FBC6A784C

P698

Q30410885-EF133025-6895-484A-9ACC-A251F52C8F72

P921

Q30410885-1BC388B2-C37D-4F41-83AE-FF5460320A3C

P932

Q30410885-47C73261-44E1-45ED-A805-8AB7AB88E890

P356

WNL.0B013E3182A35228

P1433

P1476

Antihypertensive drugs decreas ...... kgo Evaluation of Memory Study

@en

P2093

Annette L Fitzpatrick

http://www.w3.org/2001/XMLSchema#string

Carla I Mercado

http://www.w3.org/2001/XMLSchema#string

Claudia H Kawas

http://www.w3.org/2001/XMLSchema#string

Curt D Furberg

http://www.w3.org/2001/XMLSchema#string

Ginkgo Evaluation of Memory (GEM) Study Investigators

http://www.w3.org/2001/XMLSchema#string

Jeff D Williamson

http://www.w3.org/2001/XMLSchema#string

Jin Xia

http://www.w3.org/2001/XMLSchema#string

Linda P Fried

http://www.w3.org/2001/XMLSchema#string

Michelle C Carlson

http://www.w3.org/2001/XMLSchema#string

Qian-Li Xue

http://www.w3.org/2001/XMLSchema#string

P2860

Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia

Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

Ginkgo biloba for prevention of dementia: a randomized controlled trial.

The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia.

The Modified Mini-Mental State (3MS) examination.

The age-dependent relation of blood pressure to cognitive function and dementia.

Recruitment of the elderly into a pharmacologic prevention trial: the Ginkgo Evaluation of Memory Study experience.

P304

896-903

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0B013E3182A35228

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P50

Steven T Dekosky

P577

2013-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23911756

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3885216

http://www.w3.org/2001/XMLSchema#string